HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Managing transition - Medical follow-up care for adults with congenital heart defects].

Abstract
Currently, due to medical advances, more than 500 000 patients with congenital heart defects (CHD) are living in Germany, including more than 330 000 adults. In CHD, the aspect of transition from childhood and adolescence to adulthood is becoming increasingly important to ensure long-term success of the provided treatments. This is so important because despite primarily successful treatments, residua and sequels as well as (non-) cardiac comorbidities may influence the chronic course of the disease and lead to increased morbidity and mortality. Adults with congenital heart defects in Germany are insufficiently managed by existing specialized and accredited care structures, despite the great need for follow-up, and their care is largely provided by primary care physicians (general practitioners and internists) and non-specialized cardiologists.Optimized, future-oriented care requires regular follow-up and the possibility of interdisciplinary, integrated medical care of CHD in the long-term course.
AuthorsHarald Kaemmerer, Caroline Andonian, Peter Ewert, Sebastian Freilinger, Nicole Nagdyman, Rhoia Neidenbach, Jörg Schelling, Michael Huntgeburth
JournalDeutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr) Vol. 146 Issue 18 Pg. 1192-1199 (09 2021) ISSN: 1439-4413 [Electronic] Germany
Vernacular TitleTransition – Nachsorge für Erwachsene mit angeborenen Herzfehlern.
PMID34521124 (Publication Type: Journal Article)
CopyrightThieme. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Aftercare
  • Child
  • Comorbidity
  • Germany
  • Heart Defects, Congenital (epidemiology, therapy)
  • Humans
  • Transition to Adult Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: